Breaking Gene Therapy News
-
Cancer Gene Therapy Market to Witness an Outstanding Growth by Forecast 2025 - Medgadget (blog)
Aug 22, 2017 | 09:32 amCancer Gene Therapy Market to Witness an Outstanding Growth by Forecast 2025Medgadget (blog)Gene therapy is a massive and swiftly expanding field that could hold promising cures and treatments for several diseases and genetic problems. One of the more innovative segments in gene therapy falls under cancer treatment. It is one of the widely ...
Read more... -
Spark's Gene Therapy SPK-8011 to Treat Hemophilia A and B Advance in Clinical Trials - Hemophilia News Today
Aug 21, 2017 | 14:12 pmHemophilia News TodaySpark's Gene Therapy SPK-8011 to Treat Hemophilia A and B Advance in Clinical TrialsHemophilia News TodayThree patients who received SPK-8011 — a gene therapy developed by Spark Therapeutics — for hemophilia A show increased production of clotting factor VIII without any safety issues reported, says the company. The patients are the first to receive the ...
Read more... -
Cancer Gene Therapy Market Opportunities, In-Depth Analysis, Challenges and Applications Forecast to 2022 - DailyNewsKs
Aug 21, 2017 | 11:22 amDailyNewsKsCancer Gene Therapy Market Opportunities, In-Depth Analysis, Challenges and Applications Forecast to 2022DailyNewsKsThe Global Cancer Gene Therapy Market to GROW at a CAGR of 20.63% during the period 2017-2021. Cancer Gene Therapy Market Report focuses on the major drivers and restraints for the key players. These Research Report also provides granular ...and more »
Read more... -
YOUR HEALTH Gene therapy for better eyesight - WQAD.com
Aug 19, 2017 | 01:28 amWQAD.comYOUR HEALTH Gene therapy for better eyesightWQAD.comGAINESVILLE, Florida – Imagine only being able to see the things in front of you in soft focus, and just in black and white. For people with the genetic eye condition achromatopsia, those are just some of the side effects. Each time Tara Cataldo ...
Read more... -
Gene Therapy Can Restore Rare Immunodeficiency - The Independent
Aug 18, 2017 | 20:19 pmThe IndependentGene Therapy Can Restore Rare ImmunodeficiencyThe IndependentResearchers through a recent study have found out that gene therapy can be used for the treatment of the people who suffer from severe combined immunodeficiency (SCID-X1). Although the condition is the most common type of immune-deficiency disorder, ...
Read more... -
Cellectis Starts BPDCN Phase I Trial with Gene-Edited CAR-T Therapy - Genetic Engineering & Biotechnology News
Aug 18, 2017 | 15:48 pmCellectis Starts BPDCN Phase I Trial with Gene-Edited CAR-T TherapyGenetic Engineering & Biotechnology NewsCellectis reported that the first patient has been dosed in a Phase I clinical trial evaluating its TALEN® gene-edited chimeric antigen receptor (CAR) T-cell product UCART123 in patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN). The ...and more »
Read more... -
2017 Global PharmaSphere: Emerging Biotechnologies-Gene Therapy Market – Inc., Amarna Therapeutics, AnGes MG ... - DailyHover
Aug 18, 2017 | 13:27 pmDailyHover2017 Global PharmaSphere: Emerging Biotechnologies-Gene Therapy Market – Inc., Amarna Therapeutics, AnGes MG ...DailyHoverGlobal PharmaSphere Emerging Biotechnologies-Gene Therapy Market The report about Global PharmaSphere: Emerging Biotechnologies-Gene Therapy Market 2017 constitutes of pervasive fundamental research along with a structured analysis of ...
Read more... -
ACF Bioservices completes cGMP-compliant testing facility for gene and cell therapy products - BSA bureau (press release)
Aug 18, 2017 | 08:17 amBSA bureau (press release)ACF Bioservices completes cGMP-compliant testing facility for gene and cell therapy productsBSA bureau (press release)These potency assays range from relatively simple protocols to more complex and elaborate designs that determine the mechanism of action of a gene therapy product. Singapore- ACF Bioservices (an Absorption Systems company) announces the ...and more »
Read more... -
Cancer Gene Therapy Market Research Report 2022: Competitive Analysis - DailyNewsKs
Aug 18, 2017 | 08:12 amCancer Gene Therapy Market Research Report 2022: Competitive AnalysisDailyNewsKsThe Cancer Gene Therapy market report includes a comprehensive analysis of the present state of the market. The report starts with the basic Cancer Gene Therapy industry overview and then goes into each and every detail. The Global Cancer Gene ...and more »
Read more... -
BioMarin to Include Additional Phase 3 Trial for Hemophilia A Gene Therapy - Specialty Pharmacy Times
Aug 17, 2017 | 17:37 pmBioMarin to Include Additional Phase 3 Trial for Hemophilia A Gene TherapySpecialty Pharmacy TimesAn additional phase 3 study investigating the novel gene therapy BMN 270 for the treatment of hemophilia A will be added as part of BioMarin Pharmaceutical's development plan for the drug. Two separate studies will be conducted to examine the safety ...
Read more...